TipRanks
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market
MBRX
Moleculin Biotech
RESEARCH TOOLSreports
Want to see MBRX full AI Analyst Report?

Moleculin Biotech (MBRX) Stock News & Sentiment

2,019 Followers
Moleculin Biotech Updates Investors With New Presentation
Premium
Company Announcements
Moleculin Biotech Updates Investors With New Presentation
3d ago
8K
MBRX
Sara Nik Reiterates Buy on Moleculin as MIRACLE Trial De‑Risks AnnAraC; $3 Price Target Maintained
Premium
Ratings
Sara Nik Reiterates Buy on Moleculin as MIRACLE Trial De‑Risks AnnAraC; $3 Price Target Maintained
9d ago
MBRX
Moleculin Completes Enrollment in Pivotal AML Trial
Premium
Company Announcements
Moleculin Completes Enrollment in Pivotal AML Trial
9d ago
8K
MBRX
Moleculin Highlights Annamycin Cardiac Safety in New Analysis
Premium
Company Announcements
Moleculin Highlights Annamycin Cardiac Safety in New Analysis
10d ago
8K
MBRX
Moleculin Highlights Immune-Driven Annamycin Pancreatic Cancer Data
Premium
Company Announcements
Moleculin Highlights Immune-Driven Annamycin Pancreatic Cancer Data
13d ago
8K
MBRX
Moleculin Secures Mexican Patent Strengthening Annamycin IP Portfolio
Premium
Company Announcements
Moleculin Secures Mexican Patent Strengthening Annamycin IP Portfolio
15d ago
8K
MBRX
Moleculin Biotech Faces Nasdaq Delisting Risk After Notice
Premium
Company Announcements
Moleculin Biotech Faces Nasdaq Delisting Risk After Notice
20d ago
8K
MBRX
More MBRX News >

MBRX News on the Web

Analysts Are Bullish on These NA Stocks: Moleculin Biotech (MBRX), Alphabet Class A (GOOGL)
TipRanks News
Bullish
Moleculin Biotech Faces Nasdaq Delisting Risk After Notice
TipRanks News
Bearish
Why Now On-Demand Conference Spotlights Nine Emerging Biotech And Healthcare Stories
rttnews
Bullish
Analyst Maintains Buy on Advancing MIRACLE Phase 3 Trial, Trims Price Target to $3 on Financing Dilution
TipRanks News
Bullish
Moleculin: Buy Rating Maintained as MIRACLE Trial Progress Offsets Dilution; McCarthy Trims Price Target After Equity Financing
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Moleculin Biotech (MBRX), Addus Homecare (ADUS) and Rhythm Pharmaceuticals (RYTM)
TipRanks News
Bullish
Moleculin Biotech completes $9.3M equity financing
TipRanks News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: ADC Therapeutics (ADCT), Moleculin Biotech (MBRX)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
MBRX
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.25 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MBRX’s Media Buzz Sentiment?
1 articles about MBRX were published this week. In an average week, 3.25 articles are published.
    What is MBRX’s weekly average amount of articles?
    In an average week, 3.25 articles about MBRX are published.
      What is MBRX’s News Sentiment?
      50% of articles about MBRX were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XENEXenon
        ABTAbbott Laboratories
        BBIOBridgeBio Pharma
        BDXBecton Dickinson
        NVSNovartis
        Showing the stocks with the most bullish news sentiment over the past week